Reuters logo
BRIEF-‍Nicox enters research collaboration with Re-Vana Therapeutics
October 20, 2017 / 5:41 AM / a month ago

BRIEF-‍Nicox enters research collaboration with Re-Vana Therapeutics

Oct 20 (Reuters) - Nicox Sa

* ‍Nicox enters research collaboration with Re-Vana Therapeutics on its next generation of stand-alone no-donors in a novel sustained release ophthalmic formulation​

* Says ‍under terms of agreement, Re-Vana will be responsible for development and characterization of eyelief​

* Says ‍payments by Nicox associated with this agreement are not considered material to Nicox’s financial statements at this time​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below